| Name | Title | Contact Details |
|---|
Unlike traditional approaches that only address symptoms, Cardionomic addresses the conditions root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output therefore increasing renal flow and end organ perfusion. Benignly increasing contractility decreases negative hormonal signaling, and improves in-hospital morbidity/mortality. This breakthrough therapy is also expected to increase pharmacological tolerance at discharge, which will reduce costly readmission and extend life. Spun off from Denali Medical II, a New Enterprise Associates (NEA) backed incubator, Cardionomic is funded by NEA, Greatbatch Medical and Cleveland Clinic Foundation.
Biotechnology Council of New Jersey, Inc. is a Trenton, NJ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Ajinomoto USA Inc is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Fort Lee, NJ. To find more information about Ajinomoto USA Inc, please visit www.ajiusa.com
Dac Medical is a Southlake, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
meddev-corp is a Sunnyvale, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.